期刊文献+

非霍奇金淋巴瘤p27^(kipl)的表达及意义

The Expression and Clinical Significance of p27^(kipl) in Non-Hodgkin' , Lymphoma
下载PDF
导出
摘要 目的 :探讨非霍奇金淋巴瘤 (NHL)中 p2 7kipl的表达情况及其临床病理意义。方法 :采用免疫组化S -P法检测 42例NHLp2 7kipl蛋白的表达 ,并结合临床病理资料进行分析。结果 :p2 7kipl蛋白阳性表达率为 5 7% ,p2 7kipl蛋白阳性表达与组织恶性程度和临床分期明显相关 (P <0 0 5 ) ,而与患者性别、年龄、免疫分型、临床症状及部位 (结内或结外 )无明显相关 (P >0 0 5 ) ,p2 7kipl阳性病例治疗有效率明显高于 p2 7kipl阴性病例的有效率。结论 :p2 7kipl蛋白表达下降可作为NHL恶性程度的指标和预后指标 。 Objective:To investigate the expression of p27 kipl in non-Hodgkin , s lymphoma (NHL)and its clinicopathological significance .Methods: Expression of p27 kipl in 42 patients with NHL was measured using immunohistochemical technique,and analysed together with clinicopathological data. Results: The frequency of p27 kipl expression was 57%.The positive expression was strongly correlated with degree of tissue malignancy and its clinical staging (P<0 05).It was not significantly related to factors such as sex ,age ,immunophenotype,clinical symptoms and its location inside or outside lymph nodes (P>0 05).The therapy effect on NHL patients with p27 kipl poisitive was significantly better than that on NHL patients with p27 kipl negative (P<0 05). Conclusion: The reduction of p27 kipl protein expression could serve as an index for grading malignancy, and also a useful prognostic index that will be helpful in guiding clinical therapy.
出处 《贵阳医学院学报》 CAS 2001年第6期471-473,共3页 Journal of Guiyang Medical College
基金 贵州省卫生厅科研资助项目
关键词 淋巴瘤 非霍奇金氏 免疫组织化学 细胞周期 基因 抑制 肿瘤 lymphoma ,Non-Hodgkin , s immunohistochemistry cell cycle genes,supperssor,tumor.
  • 相关文献

参考文献9

  • 1Sherr CJ. Cancer cell cycles[ J ]. Science, 1996,276: 1672- 1677.
  • 2Toyoshima H,Hunter T. p27,a novel inhibitor of G1 cyclin-CDK protein kinase activity, is related to p21 [J].Cell, 1994,78: 67 - 74.
  • 3Muto A, Kizaki M, Yamato K, et al . 1.25 - DihydroxyvitaminD3 induces differentiation of a retinoic acidresistant acute promyelocytic leukemia cell line (UF- 1 )associated with expression of p21WAF1/CIP1 and p27kipl [J ]. Blood ,1999,93 :2 225 - 2 233
  • 4Lioyd RV ,Jin L, Qian X, et al. Aberrant p27kipl expression in endocrine and other tumors [ J ]. Am J pathol,1997,150:401 -402.
  • 5Erlanson M,Portin C, Linderholm B, et al. Expression of cyclin E and the cyclin- dependent kinese inhibitor p27 in malignant lymphoma - prognostic implications [J ]. Blood,1998,92: 770 - 777.
  • 6Yasui W,Kudo Y, Semba S, et al. Reduced expression of cyclin- dependent kinase inhibitor p27kipl is associated with advanced stage and in vasiveness of gastric cancinomes[ J ]. J pn J Cancer Res , 1997,88: 625 - 629.
  • 7Quintanilla- Martinez L, Thieblemant C, Fend F, et al Mantle cell lymphoma lack expression of p27kipl, a cyclin-dependent kinase inhibitor [J ]. Am J Pathol, 1998,153:175 - 182.
  • 8Carbone A, Gloghini A, Bowtempo D, et al . Proliferation C in HHV - 8 - positive primary effusion lymphoma is associated with expression of HHV cyclin but independent of p27kipl[J ]. Am J Pathol,2000,156:1209 - 1215.
  • 9Lioyd RV,Erickson LA,Jin L,et al . p27kipl: a multifunctional cyclin - dependent kinase inhibitor with prognostic significance in human cancers [ J ]. Am J Pathol, 1999,154:313 - 325.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部